Connor, Clark & Lunn Investment Management Ltd. - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 53 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$269,000
-30.8%
572,3210.0%0.00%
-33.3%
Q4 2015$389,000
-26.9%
572,321
+4.3%
0.00%
-25.0%
Q3 2015$532,000
+24.0%
548,521
+53.5%
0.00%0.0%
Q2 2015$429,000
+54.3%
357,321
+36.1%
0.00%
+100.0%
Q1 2015$278,000
+10.8%
262,521
+14.0%
0.00%0.0%
Q4 2014$251,000
+5.0%
230,321
+4.2%
0.00%0.0%
Q3 2014$239,000
-2.4%
221,0210.0%0.00%0.0%
Q2 2014$245,000
-4.7%
221,021
-2.1%
0.00%0.0%
Q1 2014$257,000225,7580.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders